Skip to content

Cigna likely suitor for Humana: Leerink

May 26, 2017

Leerink Partners maintains Outperform Humana (NYSE: HUM) price target of $265.00 (from $250.00)

Analyst Dr. Ana Gupte comments to clients that Humana is likely open for a sale and Cigna Corp. (NYSE: CI) is the most likely suitor. Price range for a possible deal according to Dr. Gupte is in the range of $260 to $270. Dr. Gupte also notes that Cigna may need to sell some assets, specifically Healthspring Medicare Advantage, to skirt any anti-trust concerns.

http://bit.ly/2r4Qwc9

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: